MARK H. RAVICH - Corporate Board Profile

ROCKWELL MEDICAL, INC.

Filing Date	Source Excerpt
2018-04-30	Mark H. Ravich, age 65, has been a director since June 2017. Mr. Ravich currently serves as president of Tri-Star Management, Inc., a commercial real estate management and syndication company that he co-founded in 1998.
2019-04-30	Mr. Ravich, age 66, has been a director since June 2017. He serves on the Audit Committee and Compensation Committee. 2018 Director Compensation table shows $112,500 fees earned in cash and $97,577 option awards totaling $210,077.
2020-04-20	Mark H. Ravich has been a director since June 2017. ... We have an Audit Committee which is currently comprised of Messrs. Cooper (Chairman), McLaughlin and Ravich. ... We have a Compensation Committee which is currently comprised of Ms. Colleran (Chairwoman) and Mr. Ravich. ... 2019 Director Compensation ... Mark H. Ravich ... Total ($) 197,928.
2021-04-30	Mark H. Ravich has been a director since June 2017. ... Mr. Ravich currently serves as president of Tri-Star Management, Inc. ... We believe that Mr. Ravich’s experience as a member of a board of directors of a public company, financial expertise and experience as a senior leader of his own company qualify him for service as a director of our Company.
2022-04-08	Mark H. Ravich(1)(2) 69 Director (1) Member of the Compensation Committee. (2) Member of the Audit Committee. 2021 Director Compensation: Fees Earned or Paid in cash ($) 62,410, Restricted Stock Unit Awards ($) 44,915, Option Awards ($) 42,319, Total ($) 149,644.
2023-04-17	Mark H. Ravich has been a director since June 2017. Mr. Ravich currently serves as president of Tri-Star Management, Inc., a commercial real estate management and syndication company that he co-founded in 1998. From October 2010 through December 2022, Mr. Ravich served as a director of Dilon Technologies, Inc., a designer and manufacturer of medical imaging solutions. In addition, from February 2019 to March 2023, Mr. Ravich served as a director of BioVentrix Inc., a manufacturer of devices to improve and expand the treatments available for congestive heart failure. Previously, from 1990 until its sale in 1998, Mr. Ravich served as the chief executive officer and a director of Universal International, Inc., a wholesale retail company, where he also led its IPO. From February 2013 to 2018, Mr. Ravich served as a director of Orchard Paper Products Company, a national supplier of high quality consumer tissue products, as well as chairman of its governance committee and as a member of its audit committee. From June 2004 to 2018, Mr. Ravich served as a director of MR Instruments, Inc., an independent designer and manufacturer of advanced MRI Radiofrequency coils. From 1978 to 1990, Mr. Ravich was a developer of commercial real estate where he was involved with all aspects of development, finance, construction, marketing, leasing and management of various commercial, industrial, office and multi-family real estate projects. Mr. Ravich began his career in 1975 as an account officer at Citibank N.A., where he made real estate construction loans to national real estate developers. Mr. Ravich also currently serves as a board advisor to Scidera Inc., a provider of clinical laboratory testing services, and is the chief manager of various real estate entities. Mr. Ravich graduated Magna Cum Laude from the Wharton School of the University of Pennsylvania with a B.S. and an M.B.A. degree with a major in finance. We believe that Mr. Ravich’s experience as a member of a board of directors of a public company, financial expertise and experience as a senior leader of his own company qualify him for service as a director of our Company.
2024-04-15	Mark H. Ravich has been a director since June 2017. He served on the Audit Committee and Nominating and Governance Committee during 2023. 2023 Director Compensation shows $63,294 fees earned or paid in cash and $65,000 restricted stock unit awards, totaling $128,294.